President Donald Trump's administration has decided not to cover expensive, high-demand obesity treatments under the ...

Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based ...

Clinicians should not neglect proteinuria testing in adults younger than age 40 years to identify those at high risk for sudden cardiac arrest.

While Stephen Lambert flew an L-39 Albatross in May of 2024, lifelong friend Greg Scohy was in the backseat enjoying the ...

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...

Semaglutide improved maximum walking distance in patients with type 2 diabetes and symptomatic peripheral artery disease.

For patients with polycystic kidney disease (PKD), a common genetic disorder that ravages the waste-removing organ with cysts, dialysis and transplantation are among the only treatments. More than 12.

Phase III SOUL trial shows daily oral semaglutide lowers the risk of major adverse cardiovascular events in patients with type 2 diabetes and atherosclerotic cardiovascular disease or chronic kidney ...

Comparison of eGFR change rates before and after renal internal medical referral. Before the referral (left orange), the ...

Among patients with diabetes receiving PCI, novel antidiabetic agents may reduce risk for acute kidney injury.

Prof Mignon McCulloch delivered the second inaugural lecture of the year at UCT last week, focusing on kidney diseases in Africa and beyond.

The prevalence of metabolic dysfunction–associated steatotic liver disease, chronic kidney disease, and obstructive sleep ...